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Objectives: The prevalence of nosocomial infections is between 5-15%. Reduction 
of nosocomial infections, recognition in time and adequate treatment are all empha-
sised activities of patient security. The aim of this examination is to measure theo-
retical and practical knowledge of hand hygiene of nursing students in secondary 
education. MethOds: Cross-sectional qualitative and quantitative was made, with 
non-random, accidental samples in 2014 January with the participation of stu-
dents in secondary nursing education (N= 116) to whom the rules of sepsis, asepsis 
and antisepsis, and correct hand hygiene knowledge were taught according to the 
number of lessons in the curriculum. Self-made opened and closed questionnaires 
were applied, with a focus on the knowledge of hand hygiene. The technique and 
efficiency of hygienic hand disinfection was measured with an infrared lamp. χ 2-
test, t-test, ANOVA were performed as a statistical method besides 95% probability 
(p< 0.05). Data analysis was performed with SPSS 20.0 programs. Results: The con-
cept of disinfection was known correctly by 78% of the students, the exact terminol-
ogy of nosocomial infection was known by 44%. Only 42 students thought that hands 
have the highest relevance in the transfer if infections. The preconditions of proper 
hand hygiene were indicated correctly by 11%. Examination with infrared lamp 
showed that 4 students implemented hand disinfection perfectly. The most common 
missed areas were: the back of the hand, phalanges, nails, thumb. cOnclusiOns: 
Significant reduction of nosocomial infections may and must be reached, to which 
accurate theoretical and practical education of the students is required, and the 
acquirement has to be monitored continuously and strictly.
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Objectives: To identify and understand the importance of reasons mothers of 
young children would choose to vaccinate their child (ren) against rotavirus and the 
impact of vaccine features on vaccine choice and uptake. MethOds: Women with 
children 5 years of age or younger participated in a focus group and semi-structured 
interview to: (1) identify reasons they would choose to vaccinate their children 
against rotavirus independent of the clinical features or cost of the vaccine and (2) 
identify the clinical vaccine features that would influence their decision to vaccinate 
their children. A survey instrument was developed to elicit the relative importance 
of the reasons for vaccination. The survey also included a discrete-choice experi-
ment (DCE) to elicit parents’ preferences for clinical features of hypothetical vac-
cines and likely uptake of vaccines with different clinical features and cost. The 
survey instrument was used in 15 in-depth, face-to-face interviews and the findings 
were used to refine the list of reasons and the clinical vaccine features. Results: 
Study participants identified 7 reasons influencing vaccination decisions – work 
disruptions, child-care disruptions, unplanned expenses, disruptions to routine, 
concern about child’s discomfort, concern about child’s health in the future, concern 
about spreading illness – and 6 clinical vaccine features influencing vaccine choice 
and uptake – number of illnesses prevented, severity of the illnesses prevented, 
duration of illnesses prevented by vaccine, location of vaccination (home or health 
care location), mode of administration (oral or injection), and age at which protec-
tion begins. Cost was also a relevant attribute in these decisions. The reasons for 
vaccination vary with the severity of illness. cOnclusiOns: Deciding to vaccinate 
a child against rotavirus is the result of a decision process that is influenced by 
both the impact of rotavirus on the family, the severity of illness, and the clinical 
characteristics of the vaccine itself.
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Objectives: To identify a parsimonious factor structure for the 43-item PROQOL-
HIV questionnaire as an easy-to-use instrument for measuring health-related 
quality of life in clinical studies. MethOds: Using a representative sample of 
3,022 HIV-infected patients from the Vespa2 French national survey, HRQL was 
summarized using the 8-dimension PROQOL-HIV questionnaire. Exploratory Factor 
Analysis (FA) was used to isolate 4 correlated factors. Dimensionality and internal 
consistency were checked using parallel analysis and Cronbach’s alpha. A con-
firmatory FA was applied on the international validation sample (N= 791, 8 coun-
tries). Summated scale scores were compared to individual scores computed from 
FA and partial credit models. Results: The four dimensions down to: physical 
health and symptoms (11 items, α = 0.931), health concerns and mental distress (10 
items, α = 0.908), social and intimate relationships (7 items, α = 0.898), and treatment 
impact (10 items, α = 0.936). Four items exhibited PROMAX rotated loadings < 0.4, 
three of which were found to cross-load on two factors. This four-factor solution 
suggests acceptable fit to the international validation sample (RMSEA= 0.082, 90% 
CI [0.079; 0.084]; NNFI= 0.880). Correlations between unweighted sum scale scores 
and factor or IRT scores were above 0.9 in most cases. cOnclusiOns: PROQOL-
HIV is the only specific scale taking into account patient’s experience with treat-
ment. This simplified scoring version will allow researchers and clinicians to better 
room visits and hospital admissions. Logistic regressions were constructed to esti-
mate the predictors for resource utilization, and a two-part multivariable analysis 
model was used to determine the total costs of treatment in the UK. Results: Data 
on 731 patients receiving SMV with pegylated interferon and ribavirin (PegIFN/R) 
or PegIFN/R alone were included in the analysis. While MRU was similar between 
SMV and PegIFN/R groups, MRU-related costs were significantly lower in the SMV 
group, compared to the PegIFN/R group (P< 0.05). High body mass index (P< 0.05), 
severe fibrosis (P< 0.05), shortened treatment duration from 48 to 24 weeks (P< 0.05), 
anaemia and rash during treatment (P< 0.001) were identified as predictors of hos-
pitalisation and outpatient visits and as drivers of total costs. Univariate sensitivity 
analyses demonstrated that shortened treatment duration and lower occurrence of 
rash lead to large cost savings. cOnclusiOns: This study identified both baseline 
and on-treatment antiviral therapy characteristics as drivers of MRU-related costs 
for HCV patients following antiviral therapy. The shortened treatment duration and 
reduction in adverse events due to simeprevir treatment lead to extra cost savings 
compared with PegIFN/R treatment. This suggests that there are potential patient 
management and cost-effectiveness implications associated with the choice of 
specific antiviral treatments.
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Objectives: Willingness-to-pay (WTP) to avoid morbidity is a widely-used meas-
ure of disease valuation. This paper aims to meta-analyze variation in mean-WTP 
of avoiding morbidity due to malaria. Benefits from avoiding incidences can be 
approximated for use in cost-benefit analyses (CBA). This study is an improve-
ment over an earlier meta-analysis: Double-counting is avoided (exclusion of same 
study results), new studies and explanatory variables are added (e. g. malaria 
incidence rates). More sophisticated regression techniques are employed to 
deal with issues, such as heteroscedasticity (e. g. multiple observations from a 
single study). Furthermore, other mosquito-borne diseases (filariasis, trypano-
somiasis and encephalitis) are included to test between-disease valuation dif-
ferences. MethOds: A systematic literature review was conducted, resulting in 
a database of 61 studies, yielding 200 data points. A meta-regression model was 
estimated. Dependent variable is mean-WTP per treatment per year in 2012 USD 
(Purchasing Power Parity and inflation adjusted). The explanatory variables con-
sists of (i) treatment characteristics (service, private/public goods etc.), (ii) meth-
odological characteristics (revealed vs. stated preference, WTP elicitation method, 
etc.), and (iii) sample characteristics (age, gender, exposure etc.). Results: 
Standardized mean-WTP range is 0.3 USD and 9000 USD. Data is censored: over 
70% of mean-WTP includes zero-values. Preliminary comparisons show that valu-
ation of malaria avoidance is influenced positively for altruistic interventions and 
negatively for rural samples. The latter is correlated with income- underlining the 
vulnerability of poorer people (due to higher exposure). Additionally, we find sig-
nificantly higher WTP to avoid filariasis over malaria. The meta-regression model 
explains over 30 percent of observed variation between WTP values. Predictive 
power is tested using a jackknife resampling procedure. cOnclusiOns: The 
preliminary results provide policy-makers important information on benefits to 
malaria interventions, with a special focus on rural areas. From a methodological 
perspective, meta-regression helps to improve the practice of benefit transfer, and 
generate improved predictions for CBA.
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Objectives: To assess and compare the compliance with anti-HBV antiviral oral 
drugs. MethOds: A pharmaco-epidemiological study, based on the IMS LifeLinkTM 
Treatment Dynamics (LTD) database was used to investigate the frequency and 
the regularity of patients’ deliveries on retail pharmacies for 18 months follow-up 
period between June 2012 and November 2013. Incident patients with no anti-
HBV drug deliveries within the last 3 months were included in the cohort. For the 
follow-up period, patients with no anti-HBV deliveries in a retail pharmacy within 
3 consecutive months were considered having stopped their treatment which can 
lead to an overestimation due to the double dispensing system of these drugs 
in France. Study investigated patients’ demographic characteristics, persistence 
rates, medication possession ratio (MPR) and proportion of days covered (PDC) 
according to initial molecule. Results: 793 patients (median age 50 years old) 
initiated a treatment against HBV (patient with both anti-HBV and HIV treatments 
were excluded); for the follow-up period, 5% of patients switched HBV treatment; 
32% of patients stopped their treatment for the follow-up period. Patients who 
continued their treatment are compliant as MPR is respectively of 160% and 103% 
at 6 and 12 months while PDC values are 82% and 78%. No differences stood out 
among the different treatments, especially between Tenofovir and Entecavir (the 
two often prescribed HBV drugs). Moreover older patients tend to be more compli-
ant than the youngest one. cOnclusiOns: By using the IMS Lifelink longitudinal 
database this study highlights the fact that one third of patients treated with anti-
HBV treatment stopped it within 18 months while these drugs are well tolerated. 
Therefore physicians’ challenge consists consequently in motivating patients to 
continue their treatment even they feel asymptomatic.
